These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11950561)

  • 1. Recombinant protein expression for therapeutic applications.
    Andersen DC; Krummen L
    Curr Opin Biotechnol; 2002 Apr; 13(2):117-23. PubMed ID: 11950561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerezyme--recombinant protein treatment for Gaucher's disease.
    Hoppe H
    J Biotechnol; 2000 Jan; 76(2-3):259-61. PubMed ID: 10656341
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosynthesis of polyketides in heterologous hosts.
    Pfeifer BA; Khosla C
    Microbiol Mol Biol Rev; 2001 Mar; 65(1):106-18. PubMed ID: 11238987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.
    Huang CJ; Lin H; Yang X
    J Ind Microbiol Biotechnol; 2012 Mar; 39(3):383-99. PubMed ID: 22252444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Linked glycoengineering for human therapeutic proteins in bacteria.
    Pandhal J; Wright PC
    Biotechnol Lett; 2010 Sep; 32(9):1189-98. PubMed ID: 20449632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of recombinant proteins under the control of regulatory elements of Lac operon].
    Iarotskiĭ SV; Ustiuzhanina SV
    Antibiot Khimioter; 1991 Dec; 36(12):27-33. PubMed ID: 1814271
    [No Abstract]   [Full Text] [Related]  

  • 7. Engineering the chaperone network of CHO cells for optimal recombinant protein production and authenticity.
    Jossé L; Smales CM; Tuite MF
    Methods Mol Biol; 2012; 824():595-608. PubMed ID: 22160922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in development of cell-free protein synthesis systems for fast and efficient production of recombinant proteins.
    Lee KH; Kim DM
    FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30084930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling apoptosis to optimize yields of proteins from mammalian cells.
    Zustiak MP; Dorai H; Betenbaugh MJ; Sauerwald TM
    Methods Mol Biol; 2012; 801():111-23. PubMed ID: 21987250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
    Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
    J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pHsh vectors, a novel expression system of Escherichia coli for the large-scale production of recombinant enzymes.
    Wu H; Pei J; Jiang Y; Song X; Shao W
    Biotechnol Lett; 2010 Jun; 32(6):795-801. PubMed ID: 20155484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering cell physiology to enhance recombinant protein production in Escherichia coli.
    Chou CP
    Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetically engineered drugs and their application with the example of erythropoietin].
    Donatz V; Zahner J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):440-4. PubMed ID: 11496621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bench-Scale Stirred-Tank Bioreactor for Recombinant Protein Production in Chinese Hamster Ovary (CHO) Cells in Suspension.
    Monteil DT; Kuan J
    Methods Mol Biol; 2018; 1850():133-145. PubMed ID: 30242685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement.
    Wells E; Robinson AS
    Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27933725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of excretory production of an exoglucanase from Escherichia coli with phage shock protein A (PspA) overexpression.
    Wang YY; Fu ZB; Ng KL; Lam CC; Chan AK; Sze KF; Wong WK
    J Microbiol Biotechnol; 2011 Jun; 21(6):637-45. PubMed ID: 21715971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D: -Mannitol formation from D: -glucose in a whole-cell biotransformation with recombinant Escherichia coli.
    Kaup B; Bringer-Meyer S; Sahm H
    Appl Microbiol Biotechnol; 2005 Dec; 69(4):397-403. PubMed ID: 15841369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.
    Waegeman H; Soetaert W
    J Ind Microbiol Biotechnol; 2011 Dec; 38(12):1891-910. PubMed ID: 21901404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic applications of genetic engineering].
    Descamps JL
    Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.